Scancell Holdings appoints Dr. Phil L’Huillier as new CEO
LONDON: Scancell Holdings plc (AIM: SCLP), a developer of cancer immunotherapies, has appointed Dr. Phil L’Huillier as the new Chief Executive Officer, effective November 18,...
Scancell initiates development of novel DNA vaccine against COVID-19
LONDON: Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, has initiated a research programme to develop a vaccine for COVID-19....